We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Targeting Diseased Areas using Enzyme-Sensitive Contrast Agents for MRI

By MedImaging staff writers
Posted on 16 Jun 2008
Magnetic resonance imaging (MRI) has become a standard modality in clinical diagnosis due to the use of contrast agents, which enable the contrast between healthy tissue and diseased tissue to be increased. More...
However, the agents currently used clinically do not allow the identification of particular pathologies or of the affected area of the body. The recent work of two French teams has brought hope in this area.

The recent research of two CNRS (Centre National de la Recherche Scientifique; Vandoeuvre-lès-Nancy [near Nancy], France) teams from Orleans and Gif-sur-Yvette (Orleans' Centre de Biophysique Moléculaire and the Institut de Chimie des Substances Naturelles in Gif-sur-Yvette [near Paris]) have demonstrated that by using a new class of contrast agents sensitive to enzymes, it is possible to locate the affected part of the body. The molecules act as switches--when they encounter a specific enzyme, this initiates a cascade reaction, leading to the activation of the contrast agent, which then becomes detectable in an MRI image. The systems have two positions--they are "off” in the absence of the enzyme, and "on” if present. Therefore, an image is only received when the contrast agents are activated.

The reactions caused by certain enzymes may be an indication of the state of the cells, and be interpreted as the signature of a given disease process. In the future, detection of enzymes due to these contrast agents should enable clinicians to diagnose a disease with a simple MRI examination. Moreover, the system can be modulated and is potentially applicable to a large variety of enzymes, and, therefore, pathologies.

Understanding the mechanism of these new molecules for medical imaging constitutes a major advance in visualizing molecular processes in vivo, as well as in detecting pathologies.

Founded in 1939 by French governmental decree, CNRS' goals include: to evaluate and carry out all research capable of advancing knowledge and bringing social, cultural, and economic benefits for society; contribute to the application and promotion of research results; develop scientific information and support research training; and participate in the analysis of the national and international scientific climate and its potential for evolution to develop a national policy.


Related Links:
CNRS

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Surgical System
Stealth AXiS
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.